Dilantin | Epilepsy Drug
Dilantin
(generic name: phenytoin)
is a widely-prescribed antiepileptic
drug issued for treatment of partial and generalized
tonic
clonic seizures associated with epilepsy.
The drug, developed in 1938 and currently marketed
by Pfizer,
has been linked to Stevens Johnson Syndrome (SJS).Stevens Johnson Syndrome is a severe, life-threatening condition which affects the skin and the mucous membranes. SJS typically begins with a flu-like period of fever, sore throat and headache. Victims then develop circular lesions that cover a majority of the skin. The lesions can develop into blisters and occasionally complete skin detachment.
Many experts agree that a reaction to Dilantin can cause the onset of this horrible disease. While Dilantin has been recalled numerous times since its introduction, it is still prescribed today. A recent wrongful death/survival case in Pennsylvania led to a $1,000,000 verdict as both the PRIMARY CARE PHYSICIAN and treating hospital failed to recognize the symptoms of SJS in a patient who was using Dialntin.
Most common side-effects:
• Nausea, vomiting, constipation, or diarrhea
• Mild dizziness or drowsiness
• Tender or swollen glands
• Swollen or painful gums
• Headache
• Muscle twitches
• Increased facial hair
• Swelling of breasts
• Insomnia
More severe side-effects are:
• An allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives)
• Hallucinations
• Slurred speech or staggering walk
• A rash
• Changes in vision
• Agitation
• Low blood pressure
• Slow or irregular heartbeats
• Abdominal pain, dark urine, light colored stools, or jaundice (yellow skin or eyes)
• Easy bruising or bleeding
• Swollen or tender gums
If you believe your Dilantin use has put you or a loved one in danger, please fill out our Case Review Contact Form to the right on this page to find out what your case is worth.
Dangerous Drugs
News Articles
News Articles
North Carolina Case Claims Financial Calamity From Bayer Drug
5/2/08 - Triangle Business Journal
(read more..)
Panel May Issue Subpoenas Related to FDA Approval
on Antibiotic Drug Ketek
1/28/08 - FDA
(read more..)
Second Safety Warning on Fentanyl Skin Patch
12/21/07 - FDA
(read more..)
F.D.A. Investigates Quit-Smoking Drug
11/20/07 - Associated Press
(read
more..)
Merck to Pay $4.85 Billion To Settle Most Vioxx Cases
11/09/07 - AngelReyesBlog.com
(read
more..)
Cephalon Drug Is Tied to Several Deaths
9/14/07 - The Wall Street Journal
(read
more..)
$5.5 Million Award in First Federal Fentanyl (Duragesic) Pain Patch Trial
6/19/07 - Press Release
(read
more...)